Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Spain Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20042
20054
20068
20075
20087
20097
20104
20115
20128
20137
20147
201514
20163
201710
201815
201915
20209
202119
202217
20238
202410
202513
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Terminated39
Active, not recruiting35
Recruiting23
Unknown status8
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals16
Eli Lilly and Company14
AstraZeneca13
Hoffmann-La Roche13
Bristol-Myers Squibb12
Fundación GECP11
Pfizer10
ETOP IBCSG Partners Foundation9
GlaxoSmithKline7
Merck Sharp & Dohme LLC7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung210
Lung Neoplasms37
Neoplasms16
Neoplasm Metastasis13
Melanoma12
Colorectal Neoplasms9
Pancreatic Neoplasms8
Brain Neoplasms7
Carcinoma7
Lung Diseases7

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.